ARTICLE | Clinical News
Dexmedetomidine: Phase II data
July 20, 2015 7:00 AM UTC
Top-line data from the double-blind Phase II REC-14-013 trial in 168 patients undergoing a bunionectomy showed that 50 ug Dex-IN every 6 hours for 48 hours starting on postoperative day 1 met the prim...